ImagineSoftware is Selected by Merge, an IBM Company, to Deliver State-of-the-Art Medical Billing Automation to their Customers

Published on:

ImagineSoftware today announced it has entered into a strategic agreement with Merge, an IBM company. ImagineSoftware will assume frontline support for Merge Financials and Merge Sentinel customers, and will provide an option for those customers to upgrade to Imagine's innovative platform for medical billing automation.

"The Merge-ImagineSoftware agreement is beneficial for our ambulatory customers in radiology and other specialties, and for both companies," said Anne Le Grand, vice president of imaging at IBM Watson Health. "Merge will focus on developing cloud-based, cognitively-enabled global imaging offerings – a growth area for our business – while ImagineSoftware remains focused on innovation in revenue cycle management and medical billing automation solutions."

 

ImagineSoftware serves the majority of radiologists across the United States as well as a substantial number of physicians across 25 other specialties. Merge Financials was built on an earlier version of the ImagineSoftware platform, simplifying the migration process for Merge Financials customers. Merge customers choosing to transition will enjoy the latest Imagine platform, with enhanced user experience, functionality, and performance. The same opportunity exists for customers using the Sentinel system, given Imagine's depth of experience with that system.

"This strategic move provides an excellent go-forward vehicle for Merge Financials and Merge Sentinel customers while adding like-minded organizations to the ImagineSoftware community we serve today," said Sam Khashman, CEO of ImagineSoftware. "We remain committed to delivering the most trusted and efficient billing automation and revenue cycle management platform to help improve the financial health, reputation, and patient experience for healthcare organizations."

About ImagineSoftware
ImagineSoftware is a leading provider of billing automation software and revenue management applications, offering powerful technology solutions for medical billing offices, practices, and hospitals, currently serving more than 40,000 physicians. ImagineSoftware solutions improve financial efficiency, build provider reputation, and ultimately improve patient experience. For more information, visit imagineteam.com and follow us on Twitter @ImagineTeam.

About Merge 
Merge, an IBM Company, is a leading provider of innovative enterprise imaging, interoperability and clinical systems that seek to advance healthcare. Merge's enterprise and cloud-based technologies for image intensive specialties provide access using a standard internet browser or mobile device. With solutions that have been used by providers for more than 25 years, Merge is helping to reduce costs and improve efficiencies, which enhances the quality of healthcare worldwide. For more information, visit merge.com and follow us on Twitter @MergeHealthcare.

 

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.